Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer
BackgroundBreast cancer is the most frequently diagnosed cancer and a leading cause of cancer-related death in women. Endoplasmic reticulum stress (ERS) plays a crucial role in the pathogenesis of several malignancies. However, the prognostic value of ERS-related genes in breast cancer has not been...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1178595/full |
| _version_ | 1797817491930480640 |
|---|---|
| author | Pengyu Fan Jiajia Wang Ruolei Li Kexin Chang Liuyin Liu Yaping Wang Zhe Wang Bo Zhang Cheng Ji Jian Zhang Suning Chen Rui Ling |
| author_facet | Pengyu Fan Jiajia Wang Ruolei Li Kexin Chang Liuyin Liu Yaping Wang Zhe Wang Bo Zhang Cheng Ji Jian Zhang Suning Chen Rui Ling |
| author_sort | Pengyu Fan |
| collection | DOAJ |
| description | BackgroundBreast cancer is the most frequently diagnosed cancer and a leading cause of cancer-related death in women. Endoplasmic reticulum stress (ERS) plays a crucial role in the pathogenesis of several malignancies. However, the prognostic value of ERS-related genes in breast cancer has not been thoroughly investigated.MethodsWe downloaded and analyzed expression profiling data for breast invasive carcinoma samples in The Cancer Genome Atlas-Breast Invasive Carcinoma (TCGA-BRCA) and identified 23 ERS-related genes differentially expressed between the normal breast tissue and primary breast tumor tissues. We constructed and validated risk models using external test datasets. We assessed the differences in sensitivity to common antitumor drugs between high- and low-scoring groups using the Genomics of Drug Sensitivity in Cancer (GDSC) database, evaluated the sensitivity of patients in high- and low-scoring groups to immunotherapy using the Tumor Immune Dysfunction and Exclusion (TIDE) algorithm, and assessed immune and stromal cell infiltration in the tumor microenvironment (TME) using the Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data (ESTIMATE) algorithm. We also analyzed the expression of independent factors in the prognostic model using the Western-blot analysis for correlation in relation to breast cancer.ResultsUsing multivariate Cox analysis, FBXO6, PMAIP1, ERP27, and CHAC1 were identified as independent prognostic factors in patients with breast cancer. The risk score in our model was defined as the endoplasmic reticulum score (ERScore). ERScore had high predictive power for overall survival in patients with breast cancer. The high-ERScore group exhibited a worse prognosis, lower drug sensitivity, and lower immunotherapy response and immune infiltration than did the low-ERScore group. Conclusions based on ERScore were consistent with Western-blot results.ConclusionWe constructed and validated for the first time an endoplasmic reticulum stress-related molecular prognostic model for breast cancer with reliable predictive properties and good sensitivity, as an important addition to the prognostic prediction model for breast cancer. |
| first_indexed | 2024-03-13T08:54:14Z |
| format | Article |
| id | doaj.art-536103c81ee944b9bb60e84b76595a0c |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-13T08:54:14Z |
| publishDate | 2023-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-536103c81ee944b9bb60e84b76595a0c2023-05-29T04:22:27ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.11785951178595Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancerPengyu Fan0Jiajia Wang1Ruolei Li2Kexin Chang3Liuyin Liu4Yaping Wang5Zhe Wang6Bo Zhang7Cheng Ji8Jian Zhang9Suning Chen10Rui Ling11Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaThe State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaThe State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi’an, ChinaDepartment of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi, ChinaDepartment of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaBackgroundBreast cancer is the most frequently diagnosed cancer and a leading cause of cancer-related death in women. Endoplasmic reticulum stress (ERS) plays a crucial role in the pathogenesis of several malignancies. However, the prognostic value of ERS-related genes in breast cancer has not been thoroughly investigated.MethodsWe downloaded and analyzed expression profiling data for breast invasive carcinoma samples in The Cancer Genome Atlas-Breast Invasive Carcinoma (TCGA-BRCA) and identified 23 ERS-related genes differentially expressed between the normal breast tissue and primary breast tumor tissues. We constructed and validated risk models using external test datasets. We assessed the differences in sensitivity to common antitumor drugs between high- and low-scoring groups using the Genomics of Drug Sensitivity in Cancer (GDSC) database, evaluated the sensitivity of patients in high- and low-scoring groups to immunotherapy using the Tumor Immune Dysfunction and Exclusion (TIDE) algorithm, and assessed immune and stromal cell infiltration in the tumor microenvironment (TME) using the Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data (ESTIMATE) algorithm. We also analyzed the expression of independent factors in the prognostic model using the Western-blot analysis for correlation in relation to breast cancer.ResultsUsing multivariate Cox analysis, FBXO6, PMAIP1, ERP27, and CHAC1 were identified as independent prognostic factors in patients with breast cancer. The risk score in our model was defined as the endoplasmic reticulum score (ERScore). ERScore had high predictive power for overall survival in patients with breast cancer. The high-ERScore group exhibited a worse prognosis, lower drug sensitivity, and lower immunotherapy response and immune infiltration than did the low-ERScore group. Conclusions based on ERScore were consistent with Western-blot results.ConclusionWe constructed and validated for the first time an endoplasmic reticulum stress-related molecular prognostic model for breast cancer with reliable predictive properties and good sensitivity, as an important addition to the prognostic prediction model for breast cancer.https://www.frontiersin.org/articles/10.3389/fonc.2023.1178595/fullbioinformatic analysisbreast cancerendoplasmic reticulum stressgene signatureimmune infiltrate cellsoverall survival |
| spellingShingle | Pengyu Fan Jiajia Wang Ruolei Li Kexin Chang Liuyin Liu Yaping Wang Zhe Wang Bo Zhang Cheng Ji Jian Zhang Suning Chen Rui Ling Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer Frontiers in Oncology bioinformatic analysis breast cancer endoplasmic reticulum stress gene signature immune infiltrate cells overall survival |
| title | Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer |
| title_full | Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer |
| title_fullStr | Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer |
| title_full_unstemmed | Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer |
| title_short | Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer |
| title_sort | development and validation of an endoplasmic reticulum stress related molecular prognostic model for breast cancer |
| topic | bioinformatic analysis breast cancer endoplasmic reticulum stress gene signature immune infiltrate cells overall survival |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1178595/full |
| work_keys_str_mv | AT pengyufan developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT jiajiawang developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT ruoleili developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT kexinchang developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT liuyinliu developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT yapingwang developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT zhewang developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT bozhang developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT chengji developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT jianzhang developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT suningchen developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer AT ruiling developmentandvalidationofanendoplasmicreticulumstressrelatedmolecularprognosticmodelforbreastcancer |